While there is a standard of care for relapse in multiple myeloma, the renowned experts with whom we’ve collaborated in this section point out that their colleagues may often have a different opinion about the right treatment course for a specific patient.
Certainly the risk classification assigned to your myeloma is a major driver of treatments, but there are nuances, and choosing the combination of medications which are right for you is something of an art.
Read More What’s very encouraging is that there continue to be new options, and therapies considered novel a few years ago are very quickly gaining traction. These can include immunotherapies such as CAR-T cells and a growing number of drug combinations. The myeloma specialists call them triplets, and there are even quadruplets composed of four drugs. There are also a huge number of clinical trials being conducted for multiple myeloma. SurvivorNet has extensive resources about how to access these options as well. At every stage of cancer, it is critically important to be your own advocate. For relapsed multiple myeloma it can be very challenging to discover the option that is right for you. Academic centers and large comprehensive cancer centers are places that most often have access to the latest treatments and research and its often possible to get a second opinion at one of these centers.
Learn more about SurvivorNet's rigorous medical review process.
